Approximately 80 percent of patients with bladder cancer showed a reduction in tumor size, with no reported side effects ...
GU ASCO annual meeting featured a urothelial carcinoma session and a discussant presentation by Dr. Scot Niglio discussing two abstracts: “Safety and efficacy of neoadjuvant immunotherapy with ...
13h
ABC 11 Raleigh NC on MSNAfrican Americans diagnosed with pancreatic cancer in advanced stages: 'Changes outlook on life'Severe abdominal pain was one of the first signs of pancreatic cancer for Paula Rowland. She ignored it for months. After ...
14h
Hosted on MSNAlphamab doses first subject in trial of JSKN003 for ovarian cancerAlphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results